{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:10Z","timestamp":1790484130919,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cmi.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T17:17:31Z","timestamp":1499534251000},"page":"125-132","source":"Crossref","is-referenced-by-count":55,"title":["Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review"],"prefix":"10.1016","volume":"24","author":[{"given":"P.","family":"Loubet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Burdet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Vindrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Grall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Andremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.-X.","family":"Lescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.07.003_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/QCO.0b013e32833bcc8a","article-title":"Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges","volume":"23","author":"Kern","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2017.07.003_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127385","article-title":"Staphylococcus aureus bloodstream infection and endocarditis \u2013 a prospective cohort study","volume":"10","author":"Moing","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.07.003_bib4","doi-asserted-by":"crossref","first-page":"948.e1","DOI":"10.1016\/j.cmi.2016.07.034","article-title":"Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study","volume":"22","author":"Braquet","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.07.003_bib5","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cmi.2017.07.003_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cmi.2017.07.003_bib7","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/AAC.40.12.2686","article-title":"Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model","volume":"40","author":"Soriano","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/159.1.103","article-title":"Differentiation of \u03b2-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles","volume":"159","author":"Kernodle","year":"1989","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib9","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1128\/jb.178.24.7248-7253.1996","article-title":"Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216","volume":"178","author":"Voladri","year":"1996","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2017.07.003_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/AAC.36.2.440","article-title":"Characterization of four beta-lactamases produced by Staphylococcus aureus","volume":"36","author":"Zygmunt","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/infdis\/147.6.1078","article-title":"Staphylococcal \u03b2-lactamase and efficacy of \u03b2-lactam antibiotics: in\u00a0vitro and in\u00a0vivo evaluation","volume":"147","author":"Chapman","year":"1983","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10096-014-2241-5","article-title":"Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome","volume":"34","author":"Chong","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib13","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00052-12","article-title":"Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","volume":"56","author":"Livorsi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkt254","article-title":"Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals","author":"Rinc\u00f3n","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.07.011","article-title":"The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr)","volume":"83","author":"Wi","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib16","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1128\/AAC.01517-16","article-title":"Association between Type A blaZ gene polymorphism and cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10096-016-2799-1","article-title":"Characteristics of cefazolin inoculum effect-positive methicillin-susceptible Staphylococcus aureus infection in a multicentre bacteraemia cohort","volume":"36","author":"Song","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/infdis\/141.3.331","article-title":"Importance of \u03b2-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus","volume":"141","author":"Goldman","year":"1980","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/AAC.13.1.74","article-title":"Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin","volume":"13","author":"Carrizosa","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib20","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/AAC.00856-13","article-title":"In\u00a0vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin","volume":"57","author":"Nannini","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/AAC.15.2.200","article-title":"Treatment of experimental Staphylococcus aureus abscesses: comparison of cefazolin, cephalothin, cefoxitin, and cefamandole","volume":"15","author":"Kaye","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib22","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","author":"Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/mdr.2013.0229","article-title":"Clinical implications of cefazolin inoculum effect and \u03b2-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia","volume":"20","author":"Lee","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2017.07.003_bib24","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are\u00a0all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.07.003_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","article-title":"Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"11","author":"Schweizer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib29","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2012010050","article-title":"Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD","author":"Chan","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2017.07.003_bib30","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00485-11","article-title":"Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib31","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/AAC.02800-14","article-title":"Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jac\/dku560","article-title":"Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study","volume":"70","author":"Bai","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib33","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/AAC.04677-14","article-title":"Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections","volume":"59","author":"Rao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib34","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00243-16","article-title":"Cefazolin versus nafcillin for methicillin-sensitive Staphylococcus aureus bloodstream infection in a California tertiary medical center","volume":"60","author":"Pollett","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix287","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","author":"McDanel","year":"2017","journal-title":"Clin Infect Dis [Internet]"},{"key":"10.1016\/j.cmi.2017.07.003_bib36","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/archinte.160.18.2819","article-title":"The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance","volume":"160","author":"Lee","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2017.07.003_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.cmi.2017.07.003_bib38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciu301","article-title":"Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting","volume":"59","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.07.003_bib39","first-page":"1","article-title":"The safety and economic impact of cefazolin versus nafcillin for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections","author":"Flynt","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2017.07.003_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000069712","article-title":"Biliary excretion of antimicrobial drugs","volume":"48","author":"Karachalios","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cmi.2017.07.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","author":"Bignardi","year":"1998","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2017.07.003_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/AAC.29.2.225","article-title":"The effect of antimicrobial agents on fecal flora of children","volume":"29","author":"Sakata","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/15.3.319","article-title":"The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile","volume":"15","author":"Ambrose","year":"1985","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.cmi.2017.07.003_bib44","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1007\/BF01644233","article-title":"Impact of injectable cephalosporins on the gastrointestinal microflora: observations in healthy volunteers and hospitalized patients","volume":"13","author":"Knothe","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.07.003_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s005950200105","article-title":"Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy","volume":"32","author":"Takesue","year":"2002","journal-title":"Surg Today"},{"key":"10.1016\/j.cmi.2017.07.003_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF01641676","article-title":"Penetration of cephalosporins into bone","volume":"12","author":"Cunha","year":"1984","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.07.003_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.13.3.405","article-title":"Treatment of osteomyelitis and septic arthritis with cefazolin","volume":"13","author":"Fass","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.07.003_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0002-9343(85)90262-1","article-title":"Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime","volume":"79","author":"Norrby","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2017.07.003_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-200039050-00003","article-title":"Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid","volume":"39","author":"Lutsar","year":"2000","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17303580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17303580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T09:20:55Z","timestamp":1549012855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17303580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1198743X17303580"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.07.003","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}